BRIDGEWATER, N.J. -- Sanofi-aventis U.S. announced today that the U.S. Food and Drug Administration (FDA) has approved a new one-vial formulation of its chemotherapeutic agent Taxotere® (docetaxel) Injection ConcentrateThe 1-vial Taxotere is anticipated to become available to cancer treatment

read more>>

CHAMPAIGN, Ill. -- Researchers have discovered a mechanism by which Helicobacter pylori, the only known cancer-causing bacterium, disables a tumor suppressor protein in host cellsThe new study, in the journal Oncogene, reports the discovery of a previously unknown mechanism linking H. pylori infec

read more>>

An international team of researchers led by scientists at the Virginia Bioinformatics Institute (VBI) at Virginia Tech have sequenced the genome of an Amerindian strain of the gastric bug Helicobacter pylori, confirming the out-of-Africa migration of this bacterial stowaway to the New WorldExperim

read more>>

SAN FRANCISCO -- ACT Biotech Inc., a privately held biotechnology company developing a portfolio of oral kinase inhibitors as anti-cancer drugs, announced today that the company’s highly selective oral kinase inhibitor, Telatinib, has received orphan drug designation from the U.S. Food and T

read more>>

SEATTLE – The bacterium Helicobacter pylori, which lives in the human stomach and is associated with ulcers and gastric cancer, is shaped like a corkscrew, or helixFor years researchers have hypothesized that the bacterium's twisty shape is what enables it to survive – and thrive &ndas

read more>>

Gastric cancer is the most common malignant gastrointestinal cancer and accounts for 25% of cancer deathsNuclear matrix, a filamentous protein framework for eukaryotic cellular chromatin, closely relates to DNA duplication and transcription. Research on nuclear matrix proteins will provide insight

read more>>

Gastric cancer, one of the most common types of cancer, is associated with high mortality ratesIn the last decades, a decrease in the worldwide incidence has been observed with some changes in the therapeutic and diagnostic options. However, the prognosis for this disease still remains poor, mainl

read more>>

CHAMPAIGN, lll. — Researchers report that Helicobacter pylori, the only bacterium known to survive in the harsh environment of the human stomach, directly activates an enzyme in host cells that has been associated with several types of cancer, including gastric cancerChronic infection with H

read more>>

LOS ANGELES -- Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated biotechnology company, today announced that multiple clinical studies of the chemotherapy agent ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) will be C

read more>>

CAMBRIDGE, MA - Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) today reported one-year follow-up data from a Phase I dose-escalation clinical study of Azedra(TM) demonstrating a positive safety profile and durable objective tumor responses in patients with neuroendocrine cancers, pheochromocytoma and paraganglioma.

read more>>